Correction to: Moxetumomab Pasudotox: First Global Approval

被引：0

|

作者：

Sohita Dhillon

机构：

[1] Springer,

来源：

Drugs | 2019年 / 79卷 / 1期

关键词：

D O I：

10.1007/s40265-018-1049-5

中图分类号：

学科分类号：

摘要：

The article Moxetumomab Pasudotox: First Global Approval, written by Sohita Dhillon, was originally published Online First without open access.

引用

收藏

页码：105 / 105

相关论文

共 50 条

[1] Moxetumomab Pasudotox: First Global Approval
Dhillon, Sohita
[J]. DRUGS, 2018, 78 (16) : 1763 - 1767
[2] Moxetumomab Pasudotox: First Global Approval
Sohita Dhillon
[J]. Drugs, 2018, 78 : 1763 - 1767
[3] Moxetumomab Pasudotox: First Global Approval (vol 78, pg 1763, 2018)
Dhillon, Sohita
[J]. DRUGS, 2019, 79 (01) : 105 - 105
[4] Moxetumomab pasudotox
Gourd, Katherine
[J]. LANCET ONCOLOGY, 2018, 19 (07): : 865 - 865
[5] Moxetumomab pasudotox for hairy cell leukemia: preclinical development to FDA approval
Lin, Adam Yuh
Dinner, Shira Naomi
[J]. BLOOD ADVANCES, 2019, 3 (19) : 2905 - 2910
[6] Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemia
Fancher, Karen M.
Lally-Montgomery, Zachary C.
[J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1467 - 1472
[7] Correction to: Camrelizumab: First Global Approval
Anthony Markham
Susan J. Keam
[J]. Drugs, 2019, 79 (13) : 1497 - 1497
[8] Correction to: Caplacizumab: First Global Approval
Sean Duggan
[J]. Drugs, 2018, 78 (18) : 1955 - 1955
[9] Correction to: Mirogabalin: First Global Approval
Emma D. Deeks
[J]. Drugs, 2019, 79 (4) : 469 - 469
[10] Correction to: Ivosidenib: First Global Approval
Sohita Dhillon
[J]. Drugs, 2019, 79 (1) : 107 - 107

← 1 2 3 4 5 →